CONMED CORP (CNMD:NYSE)
$35.2 -0.5 (-1.4006%)
Analysed CONMED CORP (CNMD:NYSE) News Sources
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms
02-05-2026
yahoo.com
Is CONMED Corporation (CNMD) A Good Stock To Buy Now?
03-05-2026
yahoo.com
Assessing CONMED (CNMD) Valuation After A Mixed Stretch In Recent Share Performance
04-05-2026
yahoo.com
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story?
05-05-2026
yahoo.com
[Latest] Global Flexible Endoscope Market Size/Share Worth USD 22.7 Billion by 2035 at a 6% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
11-05-2026
yahoo.com
Is the Options Market Predicting a Spike in CONMED Stock?
14-05-2026
yahoo.com
[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
18-05-2026
yahoo.com
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
20-05-2026
yahoo.com
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
25-05-2026
yahoo.com
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report?
29-05-2026
yahoo.com
What is the current price of CONMED CORP (CNMD:NYSE)?
The current price of CONMED CORP (CNMD:NYSE) is $35.2.
CONMED CORP (CNMD:NYSE) absolute price change since previous trading day?
The absolute price change of CONMED CORP (CNMD:NYSE) since the previous trading day is $-0.5.
CONMED CORP (CNMD:NYSE) percentage price change since previous trading day?
The percentage price change of CONMED CORP (CNMD:NYSE) since the previous trading day is -1.4006%.
What is the most recent average sentiment score for CONMED CORP (CNMD:NYSE)?
The most recent average sentiment score for CONMED CORP (CNMD:NYSE) is 68 out of 100.
What is the most recent average sentiment for CONMED CORP (CNMD:NYSE)?
The most recent sentiment for CONMED CORP (CNMD:NYSE) is .
SEC-8K** Filing Available For CONMED CORP (CNMD:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.